List of works - Richard E Champlin

166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials ⬇️

scientific article published on October 1, 2003

5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis

scientific article

A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia

scientific article published on 01 June 1999

A Phase 1-11 Study of High-Dose Thiotepa, Busulfan and Cyclophosphamide as a Preparative Regimen for Autologous Transplantation for Malignant Lymphoma

A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center

scientific article published on 3 July 2017

A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host disease

scientific article published on 01 September 1996

A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors

scientific article published on 01 June 2000

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma

scientific article

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.

scientific article

A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells

scientific article

A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation ⬇️

scientific article published on May 1, 1998

A new approach to simultaneously quantify both TCR α- and β-chain diversity after adoptive immunotherapy

scientific article published on 03 July 2012

A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation

scientific article published on 01 December 2019

A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts

scientific article published in March 2006

A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients

scientific article published on 01 November 2020

A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation

scientific article

A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis

scientific article

A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease

scientific article

A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy ⬇️

scientific article published on December 1, 1997

A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid

scientific article

A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results

scientific article published on 9 May 2017

A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma

scientific article

A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin&rsquo;s lymphomas ⬇️

scientific article published on April 14, 2010

A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia

scientific article published on 01 June 1992

A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.

scientific article published on 7 November 2016

AML-loaded DC generate Th1-type cellular immune responses in vitro

scientific article published on 01 January 2006

AMSA: a phase II trial in resistant and recurrent acute myelogenous leukemia

scientific article published on 01 January 1984

Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation

scientific article published on 01 December 1986

Abnormalities of myeloid progenitor cells after "successful" bone marrow transplantation

scientific article

Accelerated therapeutic progress in diffuse large B cell lymphoma

scientific article published on 28 December 2013

Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies

scientific article

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation

scientific article published on 01 March 2004

Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.

scientific article published in November 2004

Acute graft-vs.-host disease and interstitial pneumonitis interrelated problems following allogeneic bone marrow transplantation: effects of intravenous immune globulin and other interventions

scientific article published in August 1988

Acute lymphoblastic leukemia: recent advances in biology and therapy.

scientific article published on June 1989

Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia

scientific article published on 01 January 1993

Acute myelogenous leukemia: recent advances in therapy

scientific article

Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study

scientific article published on 01 January 2000

Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience

scientific article

Adenovirus infections in adult recipients of blood and marrow transplants

scientific article published on 9 March 2001

Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy

scientific article published on 13 February 2012

Adult stem cells and tissue repair

scientific article

Adverse effects of molgramostim in marrow transplant recipients

scientific article published on 01 July 1993

Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation

scientific article published on 31 March 2015

Age is a prognostic factor for the overall survival of multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation

scientific article published on 28 November 2019

Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma

scientific article published on 4 April 2017

Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy

scientific article published on 01 October 2018

Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation

scientific article published on 8 January 2018

Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia Resistant to Tyrosine Kinase Inhibitors ⬇️

scientific article published on April 28, 2011

Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results

scientific article published on 01 March 2019

Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3-ITD Allelic Ratio in FLT3-ITD-Positive Acute Myelogenous Leukemia

scientific article

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease

scientific article published on 01 May 1997

Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience

scientific article published in June 1999

Allogeneic blood stem cell transplantation in advanced hematologic cancers

scientific article published on 01 March 1997

Allogeneic blood stem cell transplantation: considerations for donors ⬇️

scientific article published on August 1, 1997

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

scientific article published on 01 October 1995

Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase

scientific article published on 01 October 1982

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

scientific article published on March 1996

Allogeneic bone marrow transplants for Fanconi anemia. A preliminary report from the International Bone Marrow Transplant Registry

scientific article published on 01 January 1992

Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia ⬇️

scientific article published on March 24, 1984

Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60–78 years of age ⬇️

scientific article published on February 17, 2011

Allogeneic haematopoietic transplantation for Richter's syndrome

scientific article published on 01 September 2000

Allogeneic hematopoietic cell transplantation for metastatic breast cancer

scientific article published on 17 December 2007

Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia

scientific article published on 26 June 2006

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

scientific article published on 17 January 2017

Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes

scientific article published on September 2013

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan

scientific article

Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control study

scientific article

Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy

scientific article

Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect

scientific article published in March 2000

Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens

scientific article

Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy

scientific article published on 01 November 1999

Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: Review of forty cases ⬇️

scientific article published on January 1, 1998

Allogeneic peripheral blood progenitor cell transplantation in solid tumors

scientific article

Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors

scientific article published on 01 November 1996

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer ⬇️

scientific article published on 01 March 1998

Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis

scientific article published on 4 August 2014

Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)

scientific article published on 01 May 2000

Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy

scientific article published on 7 March 2014

Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation

scientific article

Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure

scientific article

Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease

scientific article published on 01 September 2000

Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution

scientific article published on 28 September 2015

Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission

scientific article published on 24 January 2017

Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus

scientific article published on 01 December 1996

Allogeneic transplantation for recurrent or refractory non-Hodgkin's lymphoma with poor prognostic features after conditioning with thiotepa, busulfan, and cyclophosphamide: experience in 44 consecutive patients

scientific article published on August 1, 1997

Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia

scientific article published in May 2004

Allogenic bone marrow transplantation in chronic lymphocytic leukemia

scientific article published on 01 November 1996

Allotransplants for patients 65 years or older with high-risk acute myeloid leukemia

article

Altered gene expression in busulfan-resistant human myeloid leukemia

scientific article published on 12 March 2008

Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma

scientific article published on 2 January 2018

An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection

scientific article

Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation

scientific article

Analysis of Chimerism Following Allogeneic Bone Marrow Transplantation by Fluorescent-in-Situ Hybridization ⬇️

scientific article published on May 1, 1997

Analysis of interphase cells for the Philadelphia translocation using painting probe made by inter-Alu-polymerase chain reaction from a radiation hybrid

scientific article published on April 1994

Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation

scientific article

Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity.

scientific article

Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia ⬇️

scientific article published on 01 October 1983

Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial

scientific article published on 01 January 1983

Aplastic Anemia: Biology and Treatment

scientific article published on October 1, 1981

Are 2 cords better than 1?

scientific article published in October 2007

Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?

scientific article published on 26 January 2015

Are some cases of acute leukemia with t(8;21) hybrid leukemias?

scientific article

Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial

scientific article

Asia-Pacific Hematology Consortium Report on approach to multiple myeloma. Survey results from the 6th International Hematologic Malignancies Conference: Bridging the Gap 2015, Beijing, China.

scientific article

Assessing the charges associated with hematopoietic stem cell mobilization and remobilization in patients with lymphoma and multiple myeloma undergoing autologous hematopoietic peripheral blood stem cell transplantation

scientific article published on 16 May 2011

Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up

scientific article

Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients

scientific article published on 27 March 2015

Autologous Stem Cell Transplantation for Large B-cell Lymphoma with Secondary Central Nervous System Involvement

Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research

scientific article published on 14 September 2012

Autologous hematopoietic stem cell transplantation in light chain amyloidosis (AL) with renal involvement

scientific article published on 19 October 2015

Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.

scientific article

Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.

scientific article

Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma

scientific article published on 29 January 2007

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

scientific article published on 5 October 2015

Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients

scientific article published on 02 October 2020

B cell reconstitution after human bone marrow transplantation: recapitulation of ontogeny?

scientific article published on 01 October 1993

BCR-ABL protein expression in peripheral blood cells of chronic myelogenous leukemia patients undergoing therapy.

scientific article

Bayesian Continual Reassessment Method for Dose-Finding Trials Infusing T Cells with Limited Sample Size ⬇️

scientific article published on January 1, 2012

Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia

scientific article published on 01 September 1994

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

scientific article published on December 1991

Better allele-level matching improves transplant-related mortality after double cord blood transplantation.

scientific article

Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection.

scientific article

Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals

scientific article published on October 1996

Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges

scientific article published on 05 December 2007

Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor ⬇️

scientific article published on January 8, 2013

Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation.

scientific article published on 7 October 2009

Blood and marrow transplantation compensation: perspective in payer and provider relations

scientific article published on July 2004

Blood stem cell procurement: donor safety issues

scientific article published on June 1, 1998

Blood stem cell transplantation in older patients

scientific article published in December 2009

Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT)

scientific article published on 01 June 2000

Bone marrow aplasia associated with proliferation of large granular lymphocytes and subsequent transformation to acute lymphoblastic leukemia

scientific article

Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation

scientific article

Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma

scientific article published on 01 January 1997

Bone marrow transplantation after the Chernobyl nuclear accident

scientific article published on 01 July 1989

Bone marrow transplantation for Fanconi anemia

scientific article

Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies

scientific article

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion

scientific article

Bone marrow transplantation for severe aplastic anemia

scientific article published on August 1991

Bone marrow transplantation for severe aplastic anemia. Effect of a preparative regimen of cyclophosphamide-low-dose total-lymphoid irradiation and posttransplant cyclosporine-methotrexate therapy

scientific article published on 01 April 1990

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens

scientific article published in February 2007

Bone marrow transplantation for severe aplastic anemia: has outcome improved?

scientific article published on 01 July 1997

Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome ⬇️

scientific article published on January 1, 1992

Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia

scientific article published in September 2002

Bone marrow transplantation from identical twins in the treatment of aplastic anaemia: implication for the pathogenesis of the disease ⬇️

scientific article published on March 1, 1984

Bone marrow transplantation from unrelated donors.

scientific article published on March 1996

Bone marrow transplantation in acute leukaemia

scientific article

Bone marrow transplantation in chronic myelogenous leukemia

scientific article published on January 1988

Bone marrow transplantation in patients with leukaemia previously transfused with blood products from family members

scientific article published on 01 September 1987

Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure

scientific article published on 01 August 1990

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease

scientific article

Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors

Bone-marrow transplantation for chronic myelogenous leukaemia

scientific article published on 01 December 1985

Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplant patients

scientific article published on 01 May 2000

Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM

scientific article published on 01 October 2020

Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia

scientific article published on January 2002

CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes

scientific article published on 20 June 2018

CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans

scientific article published on 7 August 2003

CD3(+) and/or CD14(+) depletion from cord blood mononuclear cells before ex vivo expansion culture improves total nucleated cell and CD34(+) cell yields

scientific article published on 19 October 2009

CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot study

scientific article published on 01 July 2004

CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation

scientific article published on December 1995

Can Treg therapy prevent GVHD?

scientific article published on 01 January 2011

Can a female donor for a male recipient decrease the relapse rate for patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation?

scientific article

Can we cure refractory Hodgkin's lymphoma with transplantation?

scientific article published on 07 July 2020

Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma

scientific article published on 01 May 1999

Case problems in bone marrow transplantation. I. Graft failure in aplastic anemia: its biology and treatment

scientific article published on 01 October 1984

Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.

scientific article published on December 2007

Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

scientific article

Central nervous system relapse of lymphoid malignancies in adults: the role of high-dose chemotherapy

scientific article published on June 1997

Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma).

scientific article

Changing Trends in Allogeneic Bone Marrow Transplantation for Leukemia in the 1980s ⬇️

scientific article published on August 5, 1992

Characteristics and outcomes of patients with multiple myeloma who develop therapy-related myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia

scientific article

Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer

scientific article published on 01 November 1998

Chemotherapy versus transplants for acute myelogenous leukemia in second remission

scientific article

Chimeric antibody receptors (CARs): Driving T-cell specificity to enhance anti-tumor immunity ⬇️

scientific article published on January 1, 2012

Chimeric antigen receptor (CAR)-specific monoclonal antibody to detect CD19-specific T cells in clinical trials

scientific article (publication date: 2013)

Chromosome 8q24.1/c-MYC abnormality: a marker for high-risk myeloma

scientific article

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

scientific article

Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.

scientific article

Chronic leukemias: oncogenes, chromosomes, and advances in therapy

scientific article

Chronic myelogenous leukemia: recent advances

scientific article published on May 1985

Cladribine, gemcitabine, busulfan, and SAHA combination as a potential pretransplant conditioning regimen for lymphomas: A preclinical study

scientific article published on 11 March 2016

Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review

scientific article published on 2 August 2017

Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience

scientific article published on 29 August 2017

Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients ⬇️

scientific article published on 03 September 2019

Clinical application of Sleeping Beauty and artificial antigen presenting cells to genetically modify T cells from peripheral and umbilical cord blood

scientific article published on February 2013

Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation

scientific article

Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma

scientific article published in August 2004

Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures

scientific article published on 01 July 1996

Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation ⬇️

scientific article published on June 29, 2012

Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results

scientific article published on 2 November 2016

Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.

scientific article published on 11 October 2010

Collection of peripheral blood stem cells from normal donors 60 years of age or older

scientific article published on 01 May 1997

Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cells

scientific article published on 17 December 2017

Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients

scientific article published in September 1995

Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies.

scientific article

Common Emergence of Amantadine‐ and Rimantadine‐Resistant Influenza A Viruses in Symptomatic Immunocompromised Adults ⬇️

scientific article published on 01 June 1998

Community respiratory virus infections among hospitalized adult bone marrow transplant recipients

scientific article published in May 1996

Community respiratory virus infections in bone marrow transplant recipients: The M.D. Anderson Cancer Center experience ⬇️

scientific article published on January 1, 2001

Comparing transplant outcomes in ALL patients after haploidentical with PTCy or matched unrelated donor transplantation

scientific article published on 01 May 2020

Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment

scientific article published in June 2004

Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning Regimens

scientific article published on 11 January 2019

Comparison of Patient Age Groups in Transplantation for Myelodysplastic Syndrome: The Medicare Coverage With Evidence Development Study

scientific article published on 12 December 2019

Comparison of competitive-nested PCR and real-time PCR in detecting BCR-ABL fusion transcripts in chronic myeloid leukemia patients

scientific article published on December 2002

Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis

scientific article published on 01 January 1997

Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma

scientific article

Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts

scientific article

Comparison of the cytotoxicity of cladribine and clofarabine when combined with fludarabine and busulfan in AML cells: Enhancement of cytotoxicity with epigenetic modulators

scientific article published on 19 February 2015

Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity ⬇️

scientific article published on October 1, 2001

Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation

scientific article published on 15 May 2015

Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue

scientific article published in May 1997

Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas

scientific article published in April 2005

Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study

scientific article published in January 2002

Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trial

scientific article published on 22 March 2019

Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes

scientific article

Control of nosocomial Clostridium difficile transmission in bone marrow transplant patients

scientific article published on 01 March 2000

Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors

scientific article published in June 2001

Controlled trials of double beta-lactam therapy with cefoperazone plus piperacillin in febrile granulocytopenic patients

scientific article

Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity.

scientific article published on 20 July 2017

Cord blood natural killer cells exhibit impaired lytic immunological synapse formation that is reversed with IL-2 exvivo expansion.

scientific article published on September 2010

Cord-blood engraftment with ex vivo mesenchymal-cell coculture

scientific article published on December 2012

Cryofibrinogenemia and skin necrosis in a patient with diffuse large cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation

scientific article published on 01 December 2000

Curative potential of hematopoietic stem cell transplantation for advanced psoriasis

scientific article published on 03 April 2019

Current approaches to management of infections in bone marrow transplants

scientific article published on January 1989

Current evaluation of imatinib and allogeneic transplant in the treatment of chronic myeloid leukemia.

scientific article published in July 2003

Cutaneous manifestations of chronic graft-versus-host disease

scientific article published on November 2006

Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myeloma.

scientific article

Cytarabine, Ki‐67, and SOX11 in patients with mantle cell lymphoma receiving rituximab‐containing autologous stem cell transplantation during first remission ⬇️

scientific article published on June 17, 2013

Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia

scientific article published on 30 June 2020

Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning

scientific article published on 21 March 2017

Cytogenetics, donor type, and use of hypomethylating agents in myelodysplastic syndrome with allogeneic stem cell transplantation.

scientific article

Cytokine release syndrome and complete remission of extra medullary acute lymphoblastic leukemia of the breast with CAR-T and radiation therapy

scientific article published on 30 November 2020

Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: a retrospective study

scientific article published on 01 September 1999

Cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation

scientific article published on January 1990

Cytomegalovirus infections after allogeneic bone marrow transplantation

scientific article published on September 1990

Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients

scientific article published in April 2001

Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells

scientific article published on 05 July 2002

Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sézary syndrome.

scientific article published on 21 November 2002

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

scientific article published in January 2000

Daratumumab-Based Maintenance in Patients with Relapsed Multiple Myeloma after Salvage Autologous Hemaptopoietic Stem Cell Transplantation

scientific article published in 2022

Debulking blood stem cell collections by density gradient centrifugation in a closed-vessel system

scientific article published in January 1999

Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study

scientific article

Delay of Alternative Antiviral Therapy and Poor Outcomes of Acyclovir-Resistant Herpes Simplex Virus Infections in Recipients of Allogeneic Stem Cell Transplant.

scientific article published on 21 February 2018

Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34+ and CD34+ Thy-1dim CD38- progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation.

scientific article

Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing

scientific article

Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant

scientific article published on 16 July 2007

Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses

scientific article published on 01 February 1999

Designed transfer of specific immune responses with bone marrow transplantation

scientific article

Designing an ethical policy for bone marrow donation by minors and others lacking capacity

scientific article published on 01 January 2004

Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab

scientific article published on 18 March 2010

Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy

scientific article published on 08 July 2013

Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation

scientific article published on 01 December 1992

Development and validation of a risk assessment tool for BKPyV Replication in Allogeneic Stem cell Transplant Recipients

scientific article published on 30 June 2020

Differential effects of histone deacetylase inhibitors on cellular drug transporters and their implications for using epigenetic modifiers in combination chemotherapy

scientific article published on 24 August 2016

Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia

scientific article published on 7 September 2016

Discontinuation of immunosuppression for prevention of kidney graft rejection after receiving a bone marrow transplant from the same HLA identical sibling donor

scientific article

Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia

scientific article published on 01 July 2005

Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantation.

scientific article published on 17 June 2008

Do androgens enhance the response to antithymocyte globulin in patients with aplastic anemia? A prospective randomized trial

Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation

Donor Selection in T Cell–Replete Haploidentical Hematopoietic Stem Cell Transplantation: Knowns, Unknowns, and Controversies ⬇️

scientific article published on August 11, 2012

Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies

scientific article

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

scientific article published on 01 February 1997

Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center

scientific article published on 5 January 2012

Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response

scientific article published on 01 September 2004

Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis ⬇️

scientific article published on 01 January 2001

Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors.

scientific article published on 12 April 2017

Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease

scientific article published on 4 August 2009

Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation ⬇️

scientific article published on 03 October 2011

Dose Intensification of Busulfan in the Preparative Regimen is Associated with Improved Survival: A Phase I/II Controlled, Randomized Study ⬇️

scientific article published on December 7, 2012

Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.

scientific article published on 20 May 2016

Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help.

scientific article published on 23 January 2006

Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma

scientific article published on 23 December 2015

Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units

scientific article published on 01 December 2002

Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis

scientific article published on July 2010

Durable remission with salvage second autotransplants in patients with multiple myeloma

scientific article

Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant

scientific article

Durable responses with autologous hematopoietic SCT in patients with POEMS syndrome

scientific article

Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation

scientific article published on 01 June 1996

Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia

scientific article published on 12 February 2018

Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrow transplantation for chronic myeloid leukemia

scientific article published on 01 May 2000

Early myeloablative therapy for multiple myeloma.

scientific article

Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery ⬇️

scientific article published on 01 January 1998

Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis

scientific article

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

scientific article

Effect of induction cytarabine dose intensity on long-term survival in acute myelogenous leukemia: results of a randomized, controlled study

scientific article published on 01 September 1993

Effect of long-term storage in TRIzol on microarray-based gene expression profiling

scientific article published on 30 August 2010

Effect of non-permissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T cell depletion

scientific article published on 31 January 2018

Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia

scientific article published on 01 June 1993

Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia

scientific article

Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia

scientific article

Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling

scientific article published in March 2002

Effective depletion of alloreactive lymphocytes from peripheral blood mononuclear cell preparations

scientific article published on 01 January 1999

Effectiveness of an oral triazole for opportunistic mold infections in patients with cancer: experience with SCH 39304.

scientific article published in December 1993

Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis

scientific article published on 01 January 1990

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

scientific article published in July 2003

Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome

scientific article published in November 1989

Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation

scientific article published on 25 June 2007

Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab

scientific article

Endothelial Activation and Stress Index (EASIX) at Admission Predicts Fluid Overload in Recipients of Allogeneic Stem Cell Transplantation

scientific article published on 09 February 2020

Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation

scientific article published on 16 March 2015

Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy

scientific article published on 01 June 1997

Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cells

scientific article published on 10 August 2018

Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines ⬇️

scientific article published on June 9, 2012

Epstein-Barr Virus and B Cells in the Pathogenesis of Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem-Cell Transplantation

scientific article published on 18 April 2016

Epstein-Barr virus-associated, CD20- polyclonal lymphoproliferative disorder after matched unrelated donor marrow transplantation

scientific article published in November 2004

Evaluation of anti-CD5 ricin A chain immunoconjugate for prevention of acute graft-vs.-host disease after HLA-identical marrow transplantation

scientific article published on April 1, 1994

Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation

scientific article published in April 1994

Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease

scientific article published in January 2017

Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement

scientific article

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia

scientific article published on 01 September 2000

Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.

scientific article published on 12 May 2017

Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission

scientific article

Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity

scientific article published in January 2006

Ex vivo expansion of umbilical cord blood

scientific article

Ex vivo graft purging and expansion of autologous blood progenitor cell products from patients with multiple myeloma

scientific article published on 6 June 2011

Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD.

scientific article

Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?

scientific article published in January 2006

Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results

scientific article published in March 2003

Ex vivo fucosylation improves human cord blood engraftment in NOD-SCID IL-2Rγ(null) mice.

scientific article

Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim

scientific article published on 01 May 1997

Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy

scientific article

Feasibility and Reliability of Home-based Spirometry Telemonitoring in Allogeneic Hematopoietic Cell Transplant Recipients

scientific article published on 02 July 2020

Feasibility of Allografting in Patients with Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin ⬇️

scientific article published on January 10, 2013

Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome

scientific article

Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma

scientific article published on 24 August 2011

Fifty Years of Melphalan Use in Hematopoietic Stem Cell Transplantation ⬇️

scientific article published on August 24, 2012

First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia

scientific article

Fixed-dose single agent pegfilgrastim for peripheral blood progenitor cell mobilisation in patients with multiple myeloma

scientific article published on 01 June 2006

Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial

scientific article published on 01 November 2018

Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients

scientific article published on 19 December 2016

Fludarabine, cyclophosphamide, and antithymocyte globulin for matched related and unrelated allogeneic stem cell transplant in severe aplastic anemia ⬇️

scientific article published on October 12, 2010

Fludarabine, melphalan, thiotepa and anti-thymocyte globulin conditioning for unrelated cord blood transplant.

scientific article published on 3 January 2012

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience

scientific article

Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma

scientific article published in September 2002

Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir

scientific article published on 01 September 1997

Fracture risk prediction using FRAX in patients following hematopoietic stem cell transplantation

scientific article published on 04 April 2018

Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience.

scientific article published on 2 December 2017

Fucosylation with fucosyltransferase VI or fucosyltransferase VII improves cord blood engraftment

scientific article

Functional assessment and specific depletion of alloreactive human T cells using flow cytometry

scientific article published on 29 July 2004

GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation

scientific article

GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells

scientific article published on 26 February 2021

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

scientific article published on 01 February 1993

Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients

scientific article

Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma

scientific article

Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results

scientific article

Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapy

scientific article published on 15 September 2020

Generation of glucocorticoid-resistant SARS-CoV-2 T cells for adoptive cell therapy

scientific article published on 07 July 2021

Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application

scientific article published on 23 February 2016

Genetic therapy of human neoplastic disease.

scientific article published in January 1993

Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL

scientific article published on 01 March 2020

Gonadal failure after treatment of hematologic malignancies: from recognition to management for health-care providers

scientific article published on February 2008

Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets

scientific article published on 01 January 1994

Graft failure and leukemia relapse following T lymphocyte-depleted bone marrow transplants: effect of intensification of immunosuppressive conditioning

scientific article published on 01 February 1987

Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results

scientific article published on 01 February 1989

Graft--versus--breast cancer effect by allogeneic hematopoietic stem-cell transplantation: a possible new frontier

scientific article published on 16 August 2004

Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.

scientific article

Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia

scientific article published on 01 May 2007

Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia

scientific article published on 01 September 1996

Graft-vs.-malignancy with allogeneic blood stem cell transplantation: a potential primary treatment modality

scientific article

Granisetron (Kytril) plus dexamethasone for antiemetic control in bone marrow transplant patients receiving highly emetogenic chemotherapy with or without total body irradiation

scientific article published on 01 June 2000

Granulocyte colony-stimulating factor--primed allogeneic bone marrow transplants: capturing the advantages of blood stem cell transplants without increased risk of chronic graft-versus-host disease

scientific article published on 01 January 2000

HER-2/neu overexpression as a poor prognostic factor for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous stem cell transplantation ⬇️

scientific article published on December 1, 2001

HLA-DP incompatibilities and severe graft-versus-host disease in unrelated bone marrow transplants

scientific article published on 01 August 1991

HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant

scientific article published on 23 January 2019

HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission.

scientific article

HLA-mismatched bone marrow transplantation in severe aplastic anemia

scientific article published on 10 July 2017

Hairy-cell leukemia: biology and treatment

scientific article

Haploidentical 'megadose' stem cell transplantation in acute leukemia: recommendations for a protocol agreed upon at the Perugia and Chicago meetings.

scientific article

Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular Therapy

scientific article

Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial

scientific article published on 15 April 2016

Haploidentical Transplantation for Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

scientific article published on 13 September 2017

Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia

scientific article published on 14 November 2016

Haploidentical Transplants for Patients with Graft Failure After the First Allograft

scientific article published on 29 June 2020

Haploidentical Transplants for Patients with Relapse After the First Allograft

scientific article published on 03 July 2020

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

scientific article

Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation

scientific article published on 21 October 2019

Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning

scientific article published on 01 June 2019

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

scientific article

Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion

scientific article published on April 1997

Hematologic malignancies and Li-Fraumeni syndrome

scientific article published on 01 February 2019

Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China

scientific article published on 23 February 2017

Hematopoietic Cell Transplantation in 2020: Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative ⬇️

scientific article published on October 15, 2012

Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment

scientific article published on 30 April 2015

Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome: A Review ⬇️

scientific article published on October 1, 2011

Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit

scientific article published on 14 October 2013

Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapy

scientific article

Hematopoietic retroviral gene marking in patients with follicular non-Hodgkin's lymphoma

scientific article published in January 1999

Hematopoietic stem cell transplantation for chronic lymphocytic leukemia

scientific article published on 01 November 1998

Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate

scientific article published in June 1992

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters

scientific article published on 15 January 2004

Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type

scientific article

Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.

scientific article published on 19 December 2015

Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells

scientific article published on 01 March 2002

Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment

scientific article

Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes

scientific article published in March 2003

High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer

scientific article published on 01 January 2000

High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia

scientific article

High incidence of vitamin D deficiency in patients undergoing allogeneic stem cell transplantation

scientific article published on 21 September 2011

High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation

scientific article

High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation

scientific article published in February 2007

High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.

scientific article

High-dose chemotherapy and autologous peripheral blood stem cell transplantation for primary breast cancer refractory to neoadjuvant chemotherapy

scientific article published in May 2006

High-dose chemotherapy and autologous stem cell transplantation for nodular lymphocyte-predominant Hodgkin lymphoma

scientific article published on 16 March 2013

High-dose chemotherapy followed by stem cell transplantation in patients with resistant Waldenstrom's macroglobulinemia

scientific article (publication date: May 2001)

High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome ⬇️

scientific article published on January 1, 1998

High-dose chemotherapy with autologous stem cell support in patients with breast cancer ⬇️

scientific article published on August 1, 1998

High-dose chemotherapy with hematopoietic stem-cell transplantation for breast cancer: current status, future trends

scientific article

High-dose combined-modality therapy and autologous bone marrow transplantation in resistant cancer.

scientific article published in December 1981

High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results

scientific article published on 01 June 1985

High-dose gemcitabine, busulfan, and melphalan for autologous stem-cell transplant in patients with relapsed or refractory myeloma: a phase 2 trial and matched-pair comparison with melphalan

scientific article published on 15 May 2017

High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer

scientific article published on 01 June 2000

High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies

scientific article

High-dose melphalan allows durable engraftment of allogeneic bone marrow

scientific article published on 01 February 1995

High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant

scientific article published on 01 August 2000

High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma

scientific article published on 01 July 2006

High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis

scientific article published on 02 March 2015

High-dose topotecan, melphalan and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of multiple myeloma

scientific article

High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancer

scientific article published on September 2001

High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes

scientific article published on 22 July 2018

Higher Stem Cell Dose Infusion after Intensive Chemotherapy Does Not Improve Symptom Burden in Older Patients with Multiple Myeloma and Amyloidosis

scientific article

Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry

scientific article published on 01 November 2004

Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host Disease

scientific article published on 22 August 2017

How I transplant a patient with a history of invasive fungal disease

scientific article published on 26 August 2020

How does bone-marrow transplantation cure leukaemia?

scientific article published on 01 July 1984

Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicity

scientific article published on January 1, 1998

Humoral stimulation of hemopoietic progenitors from human fetal liver

scientific article published on 01 January 1982

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma

scientific article published in December 1998

Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial

scientific article published on 01 July 2020

Hyperacute GVHD: risk factors, outcomes, and clinical implications

scientific article published on 01 April 2007

Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment ⬇️

scientific article published on September 15, 1995

IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation

scientific article published on 20 July 2016

IMPS-04TUNING SENSITIVITY OF CHIMERIC ANTIGEN RECEPTOR TO EGFR DENSITY LIMITS RECOGNITION OF NORMAL TISSUE WHILE MAINTAINING POTENT ANTI-TUMOR ACTIVITY.

scientific article

Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial

scientific article published on 19 October 2016

Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial

scientific article published on 27 November 2015

Identical-twin bone marrow transplants for leukemia

scientific article published in April 1994

Identifying candidate allogeneic NK-cell donors for hematopoietic stem-cell transplantation based on functional phenotype.

scientific article

Idiopathic pneumonia syndrome after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for high-risk breast cancer

scientific article

Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity

scientific article published on 01 April 2020

Imaging of Sleeping Beauty-Modified CD19-Specific T Cells Expressing HSV1-Thymidine Kinase by Positron Emission Tomography

scientific article published on 31 May 2016

Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia.

scientific article

Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections

scientific article

Immunologic defects in young male patients with hepatitis-associated aplastic anemia

scientific article published on 01 May 1984

Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells

scientific article published in January 1988

Impact of Autologous Transplantation in Patients with Multiple Myeloma with t(11;14): A Propensity-Score Matched Analysis

scientific article published on 03 September 2019

Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma

scientific article published on 11 February 2019

Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes

scientific article published on 24 August 2017

Impact of Hepatitis B Core Antibody Seropositivity on the Outcome of Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma

scientific article published on 4 January 2017

Impact of Induction Therapy on the Outcome of Immunoglobulin Light Chain Amyloidosis after Autologous Hematopoietic Stem Cell Transplantation

scientific article published on 09 August 2018

Impact of TKI maintenance post-allogeneic transplant in Philadelphia positive acute lymphoblastic leukemia

scientific article published on 03 June 2020

Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome

scientific article published on 26 September 2018

Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.

scientific article published on 9 April 2013

Impact of complete remission with intensive therapy in patients with responsive multiple myeloma

article by R Alexanian et al published May 2001 in Bone Marrow Transplantation

Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation

scientific article published in July 2006

Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation

scientific article published on 27 February 2020

Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies

scientific article (publication date: February 2009)

Impact of high-dose chemotherapy on peripheral T-cell lymphomas

scientific article

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies

scientific article

Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation

scientific article published on 20 October 2005

Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma

scientific article

Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies

scientific article published on 01 November 1996

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia

scientific article

Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myeloma.

scientific article

Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma

scientific article

Importance of radiation therapy for breast cancer patients treated with high-dose chemotherapy and stem cell transplant

scientific article published on 01 January 2000

Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.

scientific article

Improved survival following bone marrow transplantation for aplastic anaemia ⬇️

scientific article published on 01 August 1983

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

scientific article published on 6 January 2012

Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade

scientific article

In vitro production of granulocyte-macrophage colony-stimulating factor in aplastic anemia: possible mechanisms of action of antithymocyte globulin

scientific article published on 01 July 1991

Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation

scientific article

Increased incidence of fractures in recipients of hematopoietic stem-cell transplantation.

scientific article published on 16 March 2015

Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time

scientific article

Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation

scientific article published on 6 August 2015

Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy: Guidelines for Hematopoietic Transplantation and Cellular Therapy

scientific article published on 09 March 2020

Individual physician practice variation in hematopoietic cell transplantation

scientific article published on 31 March 2008

Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005

scientific article published on 01 November 2007

Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention

scientific article

Infectious complications in cord blood and T-cell depleted haploidentical stem cell transplantation ⬇️

scientific article published on June 7, 2011

Infectious complications of bone marrow transplantation

scientific article published on March 1, 1984

Influenza A virus infections among hospitalized adult bone marrow transplant recipients.

scientific article published in April 1994

Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies.

scientific article

Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell Transplantation

scientific article published on 16 May 2018

Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

scientific article published on 21 February 2012

Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma.

scientific article

Intensive Sequential Therapy for VAD-Resistant Multiple Myeloma

scientific article published in January 1994

Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myeloma.

scientific article

Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma

scientific article published on 01 October 1999

Intensive-dose ifosfamide and etoposide with filgrastim for cytoreduction before peripheral blood stem cell collection in patients with advanced ovarian cancer

scientific article published on 01 January 2000

Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

scientific article published on 9 December 2009

Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma

scientific article published on January 1999

Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL ⬇️

scientific article published on June 25, 2012

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia

scientific article published on 29 November 2017

Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit

scientific article published in November 2003

Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies.

scientific article

Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation

scientific article

Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients

scientific article published on 01 September 1993

Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation. Preliminary results of a controlled trial

scientific article published on 01 March 1984

Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-

scientific article published in January 2002

Is a matched unrelated donor search needed for all allogeneic transplant candidates?

Is there an expiration date for a cord blood unit in storage?

scientific article

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

scientific article published on 01 February 2020

Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilization.

scientific article published on 23 July 2013

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients

scientific article published on 19 October 2016

Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells

scientific article published on 01 July 2020

Large-scale preparation of highly purified, frozen/thawed CD34+, HLA-DR- hematopoietic progenitor cells by sequential immunoadsorption (CEPRATE SC) and fluorescence-activated cell sorting: implications for gene transduction and/or transplantation

scientific article published on 01 May 1994

Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation

scientific article published on 01 June 2005

Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients

scientific article published on 01 March 1999

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

scientific article

Leptomeningeal toxoplasmosis after allogeneic marrow transplantation. Case report and review of the literature

scientific article published on April 1993

Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation

scientific article published on 01 May 2014

Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML.

scientific article

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantation

scientific article published on 13 April 2015

Leukemia relapse after allogeneic bone marrow transplantation: a review

scientific article published on 01 December 1994

Limited value of myeloablative therapy for late multiple myeloma.

scientific article

Long-Term Outcomes after Treatment with Clofarabine ± Fludarabine with Once-Daily Intravenous Busulfan as Pretransplant Conditioning Therapy for Advanced Myeloid Leukemia and Myelodysplastic Syndrome.

scientific article published on July 2016

Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation

scientific article published in January 2001

Long-term durable efficacy of autologous stem cell transplantation in POEMS syndrome

scientific article published on 21 December 2018

Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

scientific article

Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias

scientific article published in March 2003

Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes ⬇️

scientific article published on August 23, 2011

Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia

scientific article published on 25 July 2007

Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: the prognostic value of beta2-microglobulin and the tumor score

scientific article published in December 2003

Long-term follow-up of normal peripheral blood progenitor cell donors treated with filgrastim: no evidence of increased risk of leukemia development

scientific article published on 01 November 2002

Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival

scientific article published on 14 March 2017

Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis

scientific article

Long-term follow-up of patients with CLL treated with allogeneic hematopoietic transplantation

scientific article published in January 2002

Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipients

scientific article published on 01 January 1999

Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation

scientific article published on 01 January 1995

Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation

scientific article published on 31 August 2006

Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR

scientific article

Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib

scientific article published on 02 September 2018

Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas

scientific article published on 01 March 2020

Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma

scientific article published in May 2003

Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy

scientific article

Lovastatin Inhibits T-cell Proliferation While Preserving the Cytolytic Function of EBV, CMV, and MART-1-specific CTLs ⬇️

scientific article published on November 1, 2010

Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation.

scientific article published in December 2005

Low-dose alemtuzumab (Campath) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: decreased incidence of acute graft-versus-host-disease with unique pharmacokinetics

scientific article published in April 2004

Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia

scientific article

Low-dose non-glycosylated rhGM-CSF is effective for the treatment of delayed hematopoietic recovery after autologous marrow or peripheral blood stem cell transplantation.

scientific article

Lymphocyte Recovery Predicts Outcomes in Cord Blood and T Cell–Depleted Haploidentical Stem Cell Transplantation ⬇️

scientific article published on November 30, 2010

Maintenance Therapy With Immunomodulatory Drugs in Multiple Myeloma: A Meta-Analysis and Systematic Review.

scientific article

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study

scientific article

Malnutrition in older patients with cancer: Appraisal of the Mini Nutritional Assessment, weight loss, and body mass index

scientific article published on 24 August 2017

Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy Outcomes

scientific article

Management of cancer treatment-related diarrhea. Issues and therapeutic strategies

scientific article

Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect

scientific article published on 01 May 1997

Manufacture of Clinical-Grade CD19-Specific T Cells Stably Expressing Chimeric Antigen Receptor Using Sleeping Beauty System and Artificial Antigen Presenting Cells ⬇️

scientific article published on May 31, 2013

Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy

scientific article published on 01 January 1999

Matched unrelated donor bone marrow transplantation for the treatment of platinum refractory ovarian carcinoma: a case report

scientific article published in January 2004

Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma

scientific article

Mechanistic studies on the synergistic cytotoxicity of the nucleoside analogs gemcitabine and clofarabine in multiple myeloma: Relevance of p53 and its clinical implications ⬇️

scientific article published on 03 May 2013

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

scientific article

Melphalan based autologous transplant in octogenarian multiple myeloma patients

article

Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells

scientific article

Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents

Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?

scientific article published on 01 February 1993

Microbial contamination of hematopoietic progenitor cell products: clinical outcome

scientific article published on 18 June 2007

Mini-allografts: ongoing trials in humans

scientific article published on 01 February 2000

Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia

scientific article published on 22 October 2015

Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.

scientific article

Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation

scientific article published on 11 July 2019

Mobilization kinetics of CD34+/Thy-1dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors

scientific article published on 01 April 1997

Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation

scientific article published in September 2009

Molecular approaches to the diagnosis and treatment of cancer.

scientific article published in October 1993

Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation

scientific article published on 01 August 2020

Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation

scientific article published on January 1985

Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients

scientific article

Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes

scientific article published on 12 September 2016

Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning

scientific article

Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation

scientific article published on 17 April 2013

Myasthenia gravis and polymyositis in a dog following fetal hematopoietic cell transplantation

scientific article published on 01 January 1986

Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial

scientific article published on 04 April 2019

Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life

scientific article

Myeloablative therapy for primary resistant multiple myeloma.

scientific article published in August 1995

Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy

scientific article published on 01 October 2019

NK cell therapy: targeting disease relapse after hematopoietic stem cell transplantation

scientific article

National Marrow Donor Program: progress and challenges

scientific article

Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantation

scientific article published in August 2007

Neurocognitive deficits in older patients with cancer.

scientific article published on 9 March 2018

Neutropenias following allogeneic bone marrow transplantation: response to therapy with high-dose intravenous immunoglobulin

scientific article published on 01 August 1996

Non myeloablative "mini transplants".

scientific article

Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy.

scientific article

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality ⬇️

scientific article published on December 15, 2001

Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survival

scientific article

Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma

scientific article

Nonablative stem cell transplantation for older patients with acute leukemias and myelodysplastic syndromes

scientific article

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

scientific article published on 15 April 2004

Nonmyeloablative Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma ⬇️

scientific article published on September 1, 2012

Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation

scientific article

Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era.

scientific article published on January 2009

Nonmyeloablative allogeneic stem cell transplantation in relapsed/refractory chronic lymphocytic leukemia: long-term follow-up, prognostic factors, and effect of human leukocyte histocompatibility antigen subtype on outcome

scientific article

Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.

scientific article

Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation

scientific article

Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications.

scientific article

Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus

scientific article published on 01 December 2004

Nonmyeloablative stem cell transplantation for chronic myeloid leukemia

scientific article published in June 2004

Nonmyeloablative stem cell transplantation for lymphoma

scientific article published in February 2004

Norfloxacin for prevention of bacterial infections in granulocytopenic patients

scientific article published on 01 June 1987

Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients

scientific article published on 01 May 1986

Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients

scientific article published in June 1997

Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation

scientific article published on 10 September 2019

Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicity

scientific article published on 01 July 2007

Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients

scientific article

Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.

scientific article

Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.

scientific article published on 8 April 2004

Open lung biopsy in bone marrow transplant recipients has a poor diagnostic yield for a specific diagnosis

scientific article published on 01 June 2002

Optimal Threshold and Time of Absolute Lymphocyte Count Assessment for Outcome Prediction after Bone Marrow Transplantation

scientific article published on 30 October 2015

Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates

scientific article

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial

scientific article

Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection

scientific article

Outcome of Multiple Myeloma with Chromosome 1q Gain and 1p Deletion after Autologous Hematopoietic Stem Cell Transplantation: Propensity Score Matched Analysis

scientific article published on 24 December 2019

Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation.

scientific article published on December 2015

Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.

scientific article published on 2 April 2015

Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation

scientific article

Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction

scientific article

Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma.

scientific article published on 17 May 2017

Outcome of bone marrow transplantation patients requiring mechanical ventilation

scientific article

Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement

scientific article published on 16 January 2016

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

scientific article

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

scientific article published in November 2004

Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation

scientific article

Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant ⬇️

scientific article published on 15 July 2016

Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation

scientific article

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.

scientific article published on 19 October 2015

Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning.

scientific article published on 20 October 2015

Outcomes of Patients Treated and One Human Leukocyte Antigen–Mismatched Related Compared with Matched Unrelated Donors ⬇️

scientific article published on June 21, 2011

Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation Failure

scientific article published on 6 April 2015

Outcomes of Patients with Myeloid Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Matched Unrelated Donors Compared with One Human Leukocyte Antigen Mismatched Related Donors Using HLA Typing at 10 Loci ⬇️

scientific article published on October 20, 2010

Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation.

scientific article

Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years

scientific article published on 08 July 2019

Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia

scientific article published on 26 June 2019

Outcomes of autologous stem cell transplantation in patients with multiple myeloma who received dexamethasone-based nonmyelosuppressive induction therapy

scientific article published in March 2004

Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes-The MD Anderson Cancer Center experience

scientific article published on 3 February 2017

Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia

scientific article published on 22 October 2012

Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study

scientific article published on 01 June 2007

Overall survival in older patients with cancer

scientific article published on 22 September 2018

PET imaging of T cells derived from umbilical cord blood

scientific article published on 02 October 2008

PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies.

scientific article published on 22 September 2016

Paclitaxel and Trastuzumab as Maintenance Therapy in Patients with HER2-Positive Metastatic Breast Cancer Who Underwent High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

scientific article

Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy.

scientific article published on 13 July 2018

Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphoma

scientific article published on 10 February 2017

Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes.

scientific article

Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.

scientific article published on 21 December 2017

Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation

scientific article published on 09 May 2014

Peripheral blood progenitor cell transplantation: a replacement for marrow auto- or allografts

scientific article published in March 1996

Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections

scientific article published on 01 February 1997

Peripheral blood stem cell apheresis in normal donors: the neglected side

scientific article published on 01 November 1996

Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases

scientific article published on 01 April 2001

Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule

scientific article published on 01 January 2007

Phase 1 clinical trial using mbIL21 ex-vivo expanded donor-derived NK cells after haploidentical transplantation

scientific article

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

scientific article published on 29 January 2016

Phase I pharmacokinetic study of multicycle high-dose carboplatin followed by peripheral-blood stem-cell infusion in patients with cancer

scientific article published in April 1997

Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma

scientific article

Phase I study of high-dose mitomycin with autologous bone marrow support

scientific article published on 01 February 1982

Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue

scientific article published on 01 February 1997

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

scientific article published on 02 August 2016

Phase I/II Study of Dasatinib in Combination with Decitabine in Patients with Accelerated or Blast Phase Chronic Myeloid Leukemia

scientific article published on 18 July 2020

Phase I/II study of dose-intense doxorubicin/paclitaxel/cyclophosphamide with peripheral blood progenitor cells and cytokine support in patients with metastatic breast cancer

scientific article published on October 1997

Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome

scientific article published on 8 November 2007

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma

scientific article

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in O

article

Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.

scientific article published on 7 February 2015

Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma

scientific article published on 02 March 2018

Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival

scientific article published in February 2001

Phase II study of amsacrine and high-dose cytarabine for resistant acute myelogenous leukemia.

scientific article

Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin lymphoma

scientific article

Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients

scientific article published on 26 January 2012

Phase II study of unrelated cord blood transplantation for adults with high-risk hematologic malignancies

scientific article published on 07 August 2006

Phase II trial of high-dose topotecan, melphalan and CY with autologous stem cell support for multiple myeloma

scientific article

Phase II trial of hyper CVAD and dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia

scientific article published on March 2014

Pilot study of targeted skeletal radiation therapy for bone-only metastatic breast cancer

scientific article published in August 2009

Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation

scientific article published on 18 October 2018

Platelet recovery before allogeneic stem cell transplantation predicts posttransplantation outcomes in patients with acute myelogenous leukemia and myelodysplastic syndrome.

scientific article

Pneumococcal vaccination of recipients of bone marrow transplants

scientific article published on 01 September 1983

Poor hematopoietic stem cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma

scientific article published on June 2009

Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients

scientific article

Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantation

scientific article

Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors

scientific article published on 03 March 2020

Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia

scientific article published on 18 August 2016

Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection

scientific article published on 01 May 2003

Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation.

scientific article published on 28 March 2017

Predictors of inferior clinical outcome in patients with standard-risk multiple myeloma.

scientific article published on 9 November 2016

Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma

scientific article published on 09 January 2012

Pretransplant chest computed tomography screening in asymptomatic patients with leukemia and myelodysplastic syndrome

scientific article published on 12 December 2016

Prevention of CMV Reactivation in Haploidentical Stem Cell Transplantation

scientific article published on 3 October 2017

Prevention of graft rejection following bone marrow transplantation

scientific article published on 01 January 1981

Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients

scientific article published on 01 December 1995

Primary Systemic Amyloid Light Chain Amyloidosis Decompensating After Filgrastim-Induced Mobilization and Stem-Cell Collection ⬇️

scientific article published on 08 November 2010

Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs

scientific article published on 16 November 2018

Primary plasma cell leukemia: morphologic, immunophenotypic, and cytogenetic features of 4 cases treated with chemotherapy and stem cell transplantation

scientific article published on 01 October 2006

Principles of bone marrow processing and progenitor cell/mononuclear cell concentrate collection in a continuous flow blood cell separation system

scientific article published on 01 August 1995

Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium - HAPLO2016, San Diego, California, December 1, 2016.

scientific article published on 12 January 2018

Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014.

scientific article published on 12 January 2016

Prognostic Index for Critically Ill Allogeneic Transplantation Patients.

scientific article published on 3 March 2017

Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

scientific article

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.

scientific article

Prognostic factors for outcomes of patients with refractory or relapsed acute myelogenous leukemia or myelodysplastic syndromes undergoing allogeneic progenitor cell transplantation.

scientific article

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

scientific article published on 16 May 2018

Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease

scientific article published on 3 October 2016

Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia

scientific article

Prognostic value of cytogenetics in multiple myeloma

scientific article published on 01 April 1998

Prognostic value of response after upfront therapy for acute GVHD ⬇️

scientific article published on March 7, 2011

Progress in Haploidentical Stem Cell Transplantation ⬇️

scientific article published on 09 August 2011

Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation in a patient with chronic myelogenous leukemia

scientific article published in August 1996

Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer

scientific article published on 18 May 2009

Prolonged survival in acute myelogenous leukaemia without maintenance chemotherapy ⬇️

scientific article published on April 21, 1984

Prolonged survival with a longer duration of maintenance lenalidomide after autologous hematopoietic stem cell transplantation for multiple myeloma

scientific article published on 28 September 2016

Prophylactic use of immunoglobulin in bone marrow transplantation

scientific article published on 01 January 1986

Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study

scientific article

Prophylaxis of infection in bone marrow transplants

scientific article published on January 1988

Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)

scientific article published on 12 October 2006

Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell Transplantation

scientific article published on 21 May 2019

Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients

scientific article published on 03 December 2018

Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia

scientific article

Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation

scientific article published in June 1999

Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia

scientific article published on September 2009

Radiation accidents and nuclear energy: medical consequences and therapy

scientific article published on November 1988

Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant ⬇️

scientific article published on 05 December 2011

Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: follow-up at 12 years

scientific article published on 01 June 2006

Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma

scientific article published on 01 February 2000

Rapid debulking and CD34 enrichment of filgrastim-mobilized peripheral blood stem cells by semiautomated density gradient centrifugation in a closed system

scientific article published on 01 October 1996

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

scientific article published on 24 July 2003

Rapid transport and infusion of hematopoietic cells is associated with improved outcome after myeloablative therapy and unrelated donor transplant

scientific article published on May 2009

Re: Imatinib mesylate administration in the first 100 days after stem cell transplantation

scientific article published in December 2004

Receiving information on fertility- and menopause-related treatment effects among women who undergo hematopoietic stem cell transplantation: changes in perceived importance over time

scientific article published on November 2009

Recent advances in the application of gene therapy to human disease

scientific article published on November 1995

Recombinant alpha-2-interferon for hairy cell leukemia

scientific article published on 01 April 1985

Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis

scientific article published on 01 October 2006

Recombinant human thrombopoietin clinical development

scientific article

Recombinant interferon alpha-2a for treatment of herpes zoster in immunosuppressed patients with cancer

scientific article

Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.

scientific article

Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors

scientific article

Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor

scientific article published in June 2016

Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system

scientific article published on April 2008

Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1/Th17 differentiation.

scientific article

Reduced intensity conditioning for allogeneic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: where do we stand?

scientific article published on 01 June 2006

Reduced intensity vs. myeloablative conditioning with fludarabine and PK-guided busulfan in allogeneic stem cell transplantation for patients with AML/MDS

scientific article published on 10 December 2018

Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myeloma

scientific article

Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen

scientific article published on 01 May 2005

Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

scientific article published on 03 July 2003

Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes ⬇️

scientific article published on April 10, 2012

Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.

scientific article

Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia

scientific article

Refractory chronic lymphocytic leukemia complicated by hypercalcemia treated with allogeneic bone marrow transplantation. Case report and review

scientific article published on August 1994

Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD

scientific article

Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect

scientific article published on 01 May 1999

Reinventing bone marrow transplantation: reducing toxicity using nonmyeloablative, preparative regimens and induction of graft-versus-malignancy

scientific article

Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Cente

scientific article published on 22 February 2018

Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation

scientific article published on 4 January 2017

Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature

scientific article published on January 1, 1997

Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies.

scientific article

Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells ⬇️

scientific article published on 01 February 1998

Resolved Hepatitis B Virus Infection Is Not Associated with Worse Outcome after Allogeneic Hematopoietic Stem Cell Transplantation

scientific article published on 06 January 2010

Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients

scientific article published in November 1996

Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins

scientific article published in August 2001

Respiratory syncytial virus infections in children with cancer

scientific article published on August 2014

Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

scientific article

Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center

scientific article published on 01 September 2006

Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation

scientific article published on 12 July 2016

Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomes

scientific article published on 26 February 2007

Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations

scientific article

Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia

scientific article published on 30 April 2013

Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000.

scientific article published on 12 April 2018

Results with high-dose chemotherapy and unpurged autologous stem cell transplantation in 73 patients with chronic myelogenous leukemia: the MD Anderson experience

scientific article published on 01 May 1996

Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia

scientific article published on 01 February 1991

Retrospective analysis of weekly intravenous immunoglobulin prophylaxis versus intravenous immunoglobulin by IgG level monitoring in hematopoietic stem cell transplant recipients ⬇️

scientific article published on November 12, 2011

Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement

scientific article

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies

scientific article published on 28 May 2007

Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation

scientific article published on 01 August 1999

Risk factors for falls in older patients with cancer.

scientific article

Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.

scientific article published in January 1996

Risk factors for relapse after complete remission with high-dose therapy for multiple myeloma

scientific article published on July 2006

Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma

scientific article

Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT

scientific article published on 17 March 2008

Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia

scientific article published in September 2005

Role of bone marrow transplantation in the treatment of hematologic malignancies and solid tumors: critical review of syngeneic, autologous, and allogeneic transplants

scientific article published on January 1, 1984

Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation

scientific article

Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells

scientific article

Romidepsin targets multiple survival signaling pathways in malignant T cells

scientific article

Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation

scientific article

Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation

scientific article published on 01 December 1997

Safety and tolerance of recombinant leukocyte A interferon in bone marrow transplant recipients

scientific article published on June 1983

Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical Trial

scientific article

Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation

scientific article published on 22 September 2005

Second HLA-identical sibling transplants for leukemia recurrence

scientific article published on 01 April 1992

Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma

scientific article published in March 2006

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

scientific article

Selective depletion of CD8 positive T-lymphocytes for prevention of graft-versus-host disease following allogeneic bone marrow transplantation

scientific article published on 01 February 1989

Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation

scientific article published on July 1990

Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia

scientific article published on 01 January 1992

Sensitive PCR-based monitoring and early detection of relapsed JAK2 V617F myelofibrosis following transplantation

scientific article published on 19 December 2017

Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma

scientific article published on 15 July 2014

Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? ⬇️

scientific article published on May 15, 1992

Significance of minimal residual disease monitoring by real-time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes

scientific article published on 26 February 2020

Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remission

scientific article

Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial

scientific article

Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.

scientific article

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease

scientific article published in August 2005

Sleeping Beauty System to Redirect T-cell Specificity for Human Applications ⬇️

scientific article published on February 1, 2013

Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations

scientific article published on June 2015

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.

scientific article published on 31 May 2016

Status of high-dose chemotherapy for breast cancer: a review

scientific article

Stem cell transplantation for chronic lymphocytic leukemia: should not more patients get a transplant?

scientific article published in August 2004

Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315I.

scientific article published in August 2010

Stem cell transplantation outcomes in lymphoblastic lymphoma

scientific article published on 27 June 2016

Stem-cell transplantation in T-cell non-Hodgkin's lymphomas

scientific article published on 05 May 2011

Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy

scientific article published on 03 July 2006

Steroid-Refractory Acute GVHD: Predictors and Outcomes.

scientific article published on 3 November 2011

Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005

scientific article published on 01 March 2007

Strongyloidiasis after unrelated nonmyeloablative allogeneic stem cell transplantation

scientific article published on 17 July 2006

Studies of decitabine with allogeneic progenitor cell transplantation

scientific article published on 01 March 1997

Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome

scientific article

Successful treatment of hepatic venoocclusive disease in a bone marrow transplant patient with orthotopic liver transplantation.

scientific article published in April 1990

Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells

scientific article published on February 2006

Survival and immune recovery in dogs following fetal liver transplantation.

scientific article

Survival benefit with imatinib mesylate therapy in patients with accelerated-phase chronic myelogenous leukemia--comparison with historic experience

scientific article published in May 2005

Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapy ⬇️

scientific article published on 01 October 1997

Survivorship in AML - a landmark analysis on the outcomes of acute myelogenous leukemia patients after maintaining complete remission for at least 3 years

scientific article published on 05 August 2020

Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients

scientific article

Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat, and bortezomib in lymphoma cells

scientific article published on 16 March 2016

Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell lines

scientific article published on 10 January 2014

Synergistic cytotoxicity of sorafenib with busulfan and nucleoside analogs in human FMS-like tyrosine kinase 3 internal tandem duplications-positive acute myeloid leukemia cells

scientific article published on 09 August 2014

Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell lines ⬇️

scientific article published on 06 December 2011

Synergistic effects of p53 activation via MDM2 inhibition in combination with inhibition of Bcl-2 or Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid leukemia blast crisis cells

scientific article published on 29 September 2015

Syngeneic blood stem cell transplantation for infectious mononucleosis-related aplastic anaemia

scientific article published on 01 July 1999

T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation

scientific article published on January 1996

T-cell depletion of HLA-identical transplants in leukemia.

scientific article published in October 1991

T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities

scientific article published on 01 June 2000

T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma

scientific article published on 01 December 1992

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.

scientific article

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.

scientific article published on December 1996

Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.

scientific article published in January 2000

Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation.

scientific article

Tacrolimus‐associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation ⬇️

scientific article published on 05 March 2013

Targeting Bruton's tyrosine kinase with ibrutinib in B-cell malignancies

scientific article

Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

scientific article published on 09 September 2020

Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells

scientific article

The Clinical Impact of Time to Response in De Novo Accelerated-Phase Chronic Myeloid Leukemia

scientific article published on 17 June 2020

The Impact of Pre-Stem Cell Transplant Ferritin Level on Late Transplant Complications: An Analysis to Determine the Potential Role of Iron Overload on Late Transplant Outcomes

scientific article

The National Marrow Donor Program’s Symposium on Hematopoietic Cell Transplantation in 2020: A Health Care Resource and Infrastructure Assessment ⬇️

scientific article published on December 14, 2011

The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cells

scientific article

The University of Texas M.D. Anderson Cancer Center experience with paclitaxel in breast cancer

scientific article published on February 1997

The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells

scientific article

The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation

scientific article published on 12 January 2012

The choice of allogeneic or autologous hematopoietic transplantation for NHL.

scientific article published in January 2002

The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation

scientific article published on 26 October 2013

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

scientific article

The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation

scientific article published on 15 January 2014

The effect of the composition of unrelated donor bone marrow and peripheral blood progenitor cell grafts on transplantation outcomes

scientific article

The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan

scientific article

The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation

scientific article published on June 1, 1997

The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis

scientific article published on 28 May 2012

The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms

scientific article published on 19 June 2008

The outcome of IgD myeloma after autologous hematopoietic stem cell transplantation is similar to other Ig subtypes

scientific article

The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation

scientific article

The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling ⬇️

scientific article published on October 8, 2010

The use of GM-CSF as an adjunct to autologous/syngeneic bone marrow transplantation: a prospective randomized controlled trial

scientific article published in January 1991

The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy

scientific article published in November 2004

Therapeutic potential of leukemia-derived dendritic cells: preclinical and clinical progress

scientific article published on January 1, 2001

Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia

scientific article

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia

scientific article published in August 2001

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: Risk factors for early regimen-related toxicity

article

Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma

scientific article published in April 2001

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution

article by Joshua N Kellner et al published 2 November 2018 in Oncotarget

Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients

scientific article published on 14 July 2020

Tolerance and efficacy of ganciclovir in the treatment of cytomegalovirus infections in immunosuppressed patients

scientific article

Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome

scientific article published on 29 March 2010

Toward eliminating HLA class I expression to generate universal cells from allogeneic donors

scientific article published on 05 June 2013

Toxicity of single daily dose gentamicin in stem cell transplantation

scientific article published in July 1999

Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients ⬇️

scientific article published on 01 September 1998

Transient neutropenia in normal donors after G-CSF mobilization and stem cell apheresis

scientific article published on 01 July 1996

Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment

scientific article

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies ⬇️

scientific article published on 01 August 1998

Transplantation of ABH incompatible bone marrow: gravity sedimentation of donor marrow

scientific article published on 01 May 1984

Transplantation of T lymphocyte depleted bone marrow to prevent graft-versus-host disease: its implications for fetal liver transplantation

scientific article published on 01 January 1985

Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial

scientific article

Treatment of AML and MDS relapsing after reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation

scientific article published on 05 July 2007

Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenib

scientific article

Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate

scientific article published on 9 October 2003

Treatment of acute myelogenous leukemia in the elderly

scientific article published on February 1989

Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy

scientific article published on 01 March 1985

Treatment of adults with acute myelogenous leukemia: prospective evaluation of high-dose cytarabine in consolidation chemotherapy and with bone marrow transplantation

scientific article published on 01 June 1987

Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors

scientific article published on 01 September 1994

Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody

scientific article published on 01 January 1984

Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial

scientific article published on 01 July 1986

Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation

scientific article published on 2 July 2007

Treatment of leukemia relapse after bone marrow transplantation with interferon-alpha and interleukin 2.

scientific article published on February 1995

Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factor

scientific article published on 01 February 1989

Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab

scientific article

Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia

scientific article published on 04 September 2015

Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

scientific article

Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

scientific article

Tyrosine kinase inhibitors as initial therapy for patients with chronic myeloid leukemia in accelerated phase

scientific article published on 09 December 2013

Umbilical cord blood-derived cells for tissue repair

scientific article

Unrelated Donor Transplantation for Acute Myelogenous Leukemia in First Remission ⬇️

scientific article published on November 16, 2010

Unrelated donor hematopoietic cell transplantation for non-hodgkin lymphoma: long-term outcomes

scientific article

Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program

scientific article published on 01 April 2000

Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant ⬇️

scientific article published on 01 December 2003

Ureidopenicillins, aztreonam, and thienamycin: efficacy as single-drug therapy of severe infections and potential as components of combined therapy

scientific article published on March 1986

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

scientific article published on 01 February 2020

Use of cytosine arabinoside and total body irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia: a multicenter survey

scientific article published on 01 January 1993

Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia

scientific article published on 01 February 1997

Use of nonmyeloablative preparative regimens for allogeneic blood stem cell transplantation: induction of graft-vs.-malignancy as treatment for malignant diseases

scientific article published on 01 January 1999

Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies ⬇️

scientific article published on 01 November 1997

Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer: a pilot trial

scientific article

Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trial.

scientific article

Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization

scientific article published in January 2002

Use of two retroviral markers to test relative contribution of marrow and peripheral blood autologous cells to recovery after preparative therapy. The University of Texas M.D. Anderson Cancer Center. Division of Medicine

scientific article

Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia

scientific article published in March 1997

Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma

scientific article published on 19 December 2017

Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation

scientific article published on 17 August 2009

Validation of a Hematopoietic Cell Transplant-Composite Risk (HCT-CR) Model for Post-transplant Survival Prediction in Patients with Hematologic Malignancies

scientific article published on 04 February 2020

Validation of the M. D. Anderson Symptom Inventory multiple myeloma module

scientific article (publication date: 5 February 2013)

Variation in supportive care practices in hematopoietic cell transplantation

scientific article published in November 2008

Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.

scientific article published on 10 June 2015

West Nile encephalitis in 2 hematopoietic stem cell transplant recipients: case series and literature review

scientific article published on 18 September 2003

Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?

scientific article

With first successful allogeneic transplantations of apheresis-derived hematopoietic progenitor cells reported, can the recruitment of volunteer matched, unrelated stem cell donors be expanded substantially?

scientific article published on 01 August 1995

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

scientific article published on 2 May 2007

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

scientific article

[Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation]

scientific article published on 01 November 1985

piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies

scientific article

List of works by Richard E Champlin

166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trials ⬇️

5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis

A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia

A Phase 1-11 Study of High-Dose Thiotepa, Busulfan and Cyclophosphamide as a Preparative Regimen for Autologous Transplantation for Malignant Lymphoma

A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center

A clinical phase I/II study of recombinant human interleukin-1 receptor in glucocorticoid-resistant graft-versus-host disease

A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.

A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells

A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation ⬇️

A new approach to simultaneously quantify both TCR α- and β-chain diversity after adoptive immunotherapy

A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation

A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts

A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients

A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation

A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis

A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease

A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy ⬇️

A randomized phase 2 trial of a preparative regimen of bortezomib, high-dose melphalan, arsenic trioxide, and ascorbic acid

A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results

A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma

A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin&amp;rsquo;s lymphomas ⬇️

A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia

A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML.

AML-loaded DC generate Th1-type cellular immune responses in vitro

AMSA: a phase II trial in resistant and recurrent acute myelogenous leukemia

Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation

Abnormalities of myeloid progenitor cells after "successful" bone marrow transplantation

Accelerated therapeutic progress in diffuse large B cell lymphoma

Activating and propagating polyclonal gamma delta T cells with broad specificity for malignancies

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation

Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.

Acute graft-vs.-host disease and interstitial pneumonitis interrelated problems following allogeneic bone marrow transplantation: effects of intravenous immune globulin and other interventions

Acute lymphoblastic leukemia: recent advances in biology and therapy.

Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia

Acute myelogenous leukemia: recent advances in therapy

Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study

Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience

Adenovirus infections in adult recipients of blood and marrow transplants

Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy

Adult stem cells and tissue repair

Adverse effects of molgramostim in marrow transplant recipients

Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation

Age is a prognostic factor for the overall survival of multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation

Age over Fifty-Five Years at Diagnosis Increases Risk of Second Malignancies after Autologous Transplantation for Patients with Hodgkin Lymphoma

Allogeneic BK Virus-Specific T Cells for Progressive Multifocal Leukoencephalopathy

Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation

Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia Resistant to Tyrosine Kinase Inhibitors ⬇️

Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results

Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3-ITD Allelic Ratio in FLT3-ITD-Positive Acute Myelogenous Leukemia

Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft-versus-host disease

Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience

Allogeneic blood stem cell transplantation in advanced hematologic cancers

Allogeneic blood stem cell transplantation: considerations for donors ⬇️

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease

Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

Allogeneic bone marrow transplants for Fanconi anemia. A preliminary report from the International Bone Marrow Transplant Registry

Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia ⬇️

Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60–78 years of age ⬇️

Allogeneic haematopoietic transplantation for Richter's syndrome

Allogeneic hematopoietic cell transplantation for metastatic breast cancer

Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan

Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: a retrospective case-control study

Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy

Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect

Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens

Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy

Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: Review of forty cases ⬇️

Allogeneic peripheral blood progenitor cell transplantation in solid tumors

Allogeneic peripheral blood stem cell transplantation using normal patient-related pediatric donors

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer ⬇️

Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis

Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy)

Allogeneic stem cell transplantation as initial salvage for patients with acute myeloid leukemia refractory to high-dose cytarabine-based induction chemotherapy

A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin’s lymphomas ⬇️